# The burden of low back pain and predictions in Asia–Pacific region, 1990–2021: a comparative analysis of China, Japan, Thailand, and Pakistan

**Authors:** Chaoshun Zheng, Haojia Huang, Longsheng Zhang, Yanzhen Wang, Jiabin Li, Yueyue Guo, Xuhui He

PMC · DOI: 10.3389/fmed.2026.1693067 · Frontiers in Medicine · 2026-02-04

## TL;DR

This study analyzes low back pain trends in four Asia-Pacific countries from 1990 to 2021 and predicts future burdens to 2050, highlighting the need for targeted health policies.

## Contribution

The study provides country-specific, gender-specific, and age-specific projections of low back pain burden in the Asia-Pacific region.

## Key findings

- Japan had the highest age-standardized rates of low back pain in 2021.
- Females consistently experienced a higher burden of low back pain than males.
- Projections suggest increasing low back pain burdens for Chinese males and Japanese females by 2050.

## Abstract

Low back pain (LBP) is a leading cause of disease burden, imposing substantial societal costs. However, compared to infectious diseases, it receives insufficient attention in the Asia-Pacific region, with limited research and resource allocation. This study examines the characteristics of LBP disease burden in representative Asia-Pacific countries—China, Japan, Thailand, and Pakistan—from 1990 to 2021, and projects trends to 2050, aiming to inform evidence-based health policies.

Utilizing Global Burden of Disease (GBD) 2021 data, we analyzed LBP incidence, prevalence, and years lived with disability (YLDs). Country comparisons employed age-standardized rates (ASRs), stratified by age groups. Joinpoint regression assessed trends during 1990–2021 and compared cross-national variations. The BAPC model was used to predict future LBP disease burdens from 2022 to 2050. Decomposition analysis quantified contributions from population aging, population growth, and epidemiological changes.

In 2021, Japan exhibited the highest ASRs, followed by China, Thailand, and Pakistan. Case counts peaked in the working-age population, while ASR peaks concentrated in middle-aged and older adult groups. Females consistently bore a higher burden than males. From 1990 to 2021, China and Japan showed declining ASR trends, whereas Thailand and Pakistan demonstrated upward ASR trends; all countries saw rising case counts. BAPC projections indicated increasing ASR burdens for Chinese males and Japanese females by 2050, with declines in other groups. Decomposition analysis revealed divergent drivers across countries.

LBP remains a major public health challenge in these representative Asia-Pacific countries, with age, gender, and national heterogeneity shaping burden dynamics. Tailored policies addressing country-specific, gender-specific, and age-specific disparities are urgently needed to mitigate the disease burden of LBP.

## Full-text entities

- **Diseases:** obese (MESH:D009765), overweight (MESH:D050177), lumbar disk herniation (MESH:D007405), LBP (MESH:D017116), metabolic syndrome (MESH:D024821), injuries (MESH:D014947), Disease (MESH:D004194), pain (MESH:D010146), cancer (MESH:D009369), work absence (MESH:D000073397), intervertebral disk degeneration (MESH:D055959), depression (MESH:D003866), chronic pain (MESH:D059350), estrogen deficiency (MESH:D056828), spinal degeneration (MESH:D009410), limitation (MESH:D045745), chronic diseases (MESH:D002908), infectious disease (MESH:D003141), YLDs (MESH:D009069), SDI (MESH:C566784), pain in the back (MESH:D001416), vertebral fractures (MESH:C535781), infections (MESH:D007239), cardiovascular diseases (MESH:D002318), osteoporosis (MESH:D010024), GBD (MESH:D001037), mental health disorders (OMIM:603663)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913483/full.md

## Figures

22 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913483/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913483/full.md

---
Source: https://tomesphere.com/paper/PMC12913483